Status | Study |
RECRUITING |
Study Name: Semaglutide in CFRD Condition: Cystic Fibrosis Date: 2023-03-15 Interventions: glucagon-like peptide 1 (GLP-1) receptor agonist |
RECRUITING |
Study Name: Health Outcomes of Parents With Cystic Fibrosis Condition: Cystic Fibrosis Date: 2023-03-08 Interventions: The aim of the study is to assess the impact parenthood has on health outcomes. |
RECRUITING |
Study Name: FEED-Cystic Fibrosis (FEED-CF) Condition: Cystic Fibrosis Date: 2023-02-21 Interventions: Consist of <5% kcal from added sugars as recommended by the American Heart Association, and the glycemic index will be 45 or lower (25% lower than |
RECRUITING |
Study Name: Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis Condition: Cystic Fibrosis Date: 2023-02-03 Interventions: A sugar alcohol indicated as an add-on maintenance therapy to improve pulmonary function in adult patients 18 years of age and older with cystic fibro |
RECRUITING |
Study Name: Fitness, Body Composition, Physical Activity and Sleep Patterns in People With Cystic Fibrosis on Modulator Therapy. Condition: Cystic Fibrosis Date: 2023-01-23 |
RECRUITING |
Study Name: The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes Condition: Cystic Fibrosis Date: 2023-01-16 Interventions: Food delivery service will provide a low glycemic load diet for 8 weeks, followed by a 4-month period of self-adherence to a low glycemic load diet wi |
Active, not recruiting |
Study Name: Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior Condition: Cystic Fibrosis Date: 2023-01-10 Interventions: Drug: Elexacaftor / Ivacaftor / TezacaftorTriple combination therapy is licensed in the UK for prescription to paediatric patients aged 6 to 11 |
RECRUITING |
Study Name: Estrogen Supplementation and Bone Health in Women With CF Condition: Cystic Fibrosis Date: 2023-01-10 Interventions: Transdermal estradiol 0.1 mg/day, applied once weekly |
RECRUITING |
Study Name: A Phase 1 Study of VX-522 in Participants With Cystic Fibrosis (CF) Condition: Cystic Fibrosis Date: 2022-12-19 Interventions: Oral inhalation using nebulizer. |
RECRUITING |
Study Name: A Phase 1 Study of VX-522 in Participants With Cystic Fibrosis (CF) Condition: Cystic Fibrosis Date: 2022-12-19 Interventions: Oral inhalation using nebulizer. |